Opsonization is a process of the immune system in which molecules called opsonins bind to a target and enhance its recognition and ingestion by phagocytosis. Targets include microorganisms, experimental particles, and dying cells. The principal opsonins involved in antimicrobial defense are antibodies and fragments of the complement system. These molecules connect a target surface to receptors on phagocytes, including neutrophils and macrophages. Opsonization promotes uptake but is distinct from ingestion itself and does not necessarily guarantee that an ingested microorganism will be killed. (pmc.ncbi.nlm.nih.gov)
Functional organization
An opsonin acts as a molecular bridge: one part or binding surface associates with the target, while another is recognized by a phagocyte. This arrangement allows immune cells to recognize many different targets through a limited set of receptors. Antibodies provide specificity for particular surface structures, whereas complement proteins can be deposited through pathways that do not require a pre-existing specific antibody response. Antibody and complement opsonization can also cooperate on the same target. (pmc.ncbi.nlm.nih.gov)
Opsonization is especially important against extracellular bacteria. Experiments with human neutrophils have shown that complement deposition can reduce the amount of target-bound antibody required for efficient uptake. Thus, opsonic activity depends not simply on whether an opsonin is present, but also on its density, accessibility, receptor interactions, and the physiological state of the responding cell. (pubmed.ncbi.nlm.nih.gov)
Antibody-mediated opsonization
Immunoglobulin G (IgG) is a major antibody opsonin. Its antigen-binding regions attach to antigens on a target, leaving its Fc region available for recognition by Fc receptors. Phagocytic Fcγ receptors recognize this Fc region and link antibody-coated targets to the cell’s uptake machinery. Consequently, target recognition and cellular activation occur through different parts of the same antibody molecule. (pmc.ncbi.nlm.nih.gov)
When multiple activating receptors engage an IgG-coated surface, they form signaling assemblies that initiate remodeling of the actin cytoskeleton. Imaging experiments in macrophages have demonstrated Fcγ-receptor microclusters associated with signaling proteins at sites of contact with IgG-bearing surfaces. These coordinated interactions support membrane extension around the target rather than merely passive attachment. (pmc.ncbi.nlm.nih.gov)
Antibody binding can also enhance complement deposition. In experiments with encapsulated Staphylococcus aureus, specific IgG increased C3 fixation and promoted ingestion in the presence of active complement. Antibody-mediated and complement-mediated opsonization are therefore interacting mechanisms, not mutually exclusive alternatives. (pubmed.ncbi.nlm.nih.gov)
Complement-mediated opsonization
The complement protein C3 is central to complement-dependent opsonization. Its cleavage generates C3b, which can become covalently attached to a target surface through a reactive thioester. Biochemical experiments showed that disrupting this reactive group prevented effective C3b attachment and the associated enhancement of phagocytosis. Covalent attachment helps retain the opsonic label on the surface where complement activation has occurred. (pubmed.ncbi.nlm.nih.gov)
C3b can subsequently be processed into iC3b. Both fragments participate in recognition by complement receptors, but their receptor preferences differ: C3b is recognized principally by CR1, while iC3b is an important ligand for CR3. Processing C3b therefore changes the target’s interactions with phagocytes rather than simply removing its opsonic function. (pmc.ncbi.nlm.nih.gov)
Complement receptor engagement can contribute to both attachment and ingestion. The balance depends on the receptor, target, and experimental conditions. Although earlier experiments emphasized C3b-assisted attachment, experiments using purified C3b attached to bacterial surfaces demonstrated that C3b alone could trigger uptake and activation of human neutrophils through CR1. A universal distinction in which complement only attaches targets and antibodies alone trigger ingestion is therefore inadequate. (pubmed.ncbi.nlm.nih.gov)
From recognition to clearance
After receptor engagement, the phagocyte reorganizes its membrane and cytoskeleton to surround the target. Uptake encloses it in a phagosome, separating the ingestion step from subsequent intracellular processing. Experiments that measure particle attachment alone consequently do not establish that complete phagocytosis has occurred; similarly, uptake measurements do not directly measure microbial survival. (pmc.ncbi.nlm.nih.gov)
Opsonization also participates in the removal of cells undergoing apoptosis, a process termed efferocytosis. The complement recognition molecule C1q can bind apoptotic cells and, in serum, promote C3b deposition and enhanced uptake. Studies comparing human monocytes, macrophages, and dendritic cells found that C1q’s effects varied with cell differentiation and the presence of other complement components. Its effects on cytokine release likewise differed among these phagocytes, showing that opsonic recognition does not impose one uniform inflammatory response. (pmc.ncbi.nlm.nih.gov)
Biological significance
Bacterial capsules can impede effective opsonic recognition. In encapsulated S. aureus, antibody altered both the amount and distribution of deposited complement, improving access to opsonic interactions. The effectiveness of a surface coating therefore depends on where its molecules are located, not solely on their total abundance. (pubmed.ncbi.nlm.nih.gov)
Defective complement-dependent opsonization contributes to some forms of immunodeficiency. Studies of sera from people deficient in complement component C2 found reduced C3b–iC3b deposition on Streptococcus pneumoniae and impaired phagocytosis. Antibody measurements alone did not fully account for these functional differences, illustrating the combined contributions of specific recognition and complement activity. (pmc.ncbi.nlm.nih.gov)
Experimental measurement
Opsonization can be assessed by measuring surface-bound antibodies or complement fragments, often using flow cytometry. Functional assays instead measure uptake or opsonophagocytic killing. These endpoints answer different questions: deposition documents coating, uptake documents ingestion, and killing assays determine the reduction in viable bacteria under defined conditions. (pmc.ncbi.nlm.nih.gov)
Opsonophagocytic assays are used in vaccine research, particularly to evaluate functional antipneumococcal antibodies. Such assays combine serum, complement, bacterial targets, and phagocytic effector cells. Standardizing these components is necessary for reproducible comparisons. Multiplexed formats allow several bacterial serotypes to be tested together, reducing sample requirements while measuring functional activity rather than antibody concentration alone. (pmc.ncbi.nlm.nih.gov)